This document discusses the etiology and clinical presentation of various causes of vaginal discharge. It covers bacterial vaginosis, trichomoniasis, vulvovaginal candidiasis, chlamydia, gonorrhea, herpes simplex virus, atrophic vaginitis, cervical cancer, and physiological discharge. For each cause, it describes associated history, risk factors, examination findings such as discharge appearance and characteristics, and signs of infection or inflammation. Differential diagnoses and recommendations for testing and treatment are also provided.
Secretions produced by the glands of vaginal wall and cervix that drain from the vaginal opening.
Vaginal discharge is a common presentation of women to the STI clinic
Can be physiological or pathological
Related with some common STIs
Secretions produced by the glands of vaginal wall and cervix that drain from the vaginal opening.
Vaginal discharge is a common presentation of women to the STI clinic
Can be physiological or pathological
Related with some common STIs
Vaginitis- vaginal discharge all medical information martinshaji
Vaginitis is the most common gynaecologic diagnosis in the primary care setting..
In approximately 90% of affected women, this condition occurs secondary to bacterial vaginitis, vulvo vaginal candidiasis or trichomoniasis. this is a study describing all the aspects of vaginal discharge associated with vaginitis , types , infections , treatment , prevention etc
please comment
thank u
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
Presentation on the description of normal and abnormal uterine bleeding, menstrual cycle, FIGO classification with PALM-COEIN, common differentials of AUB, assessment, diagnosis, and management.
Bacterial Vaginosis
Dr. Yashika
Causative agent : Gardnerella vaginalis
Clinical features:
Malodorous vaginal discharge.
(Homogenous, greyish white, adherent to vaginal wall)
No vaginal inflammation.
During pregnancy
preterm membrane rupture,
preterm labour,
chorioamnionitis.
Complications:
Recurrent infection leads to PID.
Development of PID following abortion.
Vaginal cuff cellulitis following hysterectomy.
Pregnancy complications.
Diagnosis
Amsel’s criteria :
Homogenous vaginal discharge
Vaginal discharge > 4.5
Positive whiff’s test
Presence of clue cells > 20% of cells.
Whiffs test:
Appearance of fishy (amine) odour when a drop of discharge is mixed with 10% solution of KOH.
Clue cells:
Presence of stippled epithelial cells.
Treatment:
Metronidazole 200 mg TDS x 7 days.
Clindamycin cream.
Metronidazole gel.
Vaginitis- vaginal discharge all medical information martinshaji
Vaginitis is the most common gynaecologic diagnosis in the primary care setting..
In approximately 90% of affected women, this condition occurs secondary to bacterial vaginitis, vulvo vaginal candidiasis or trichomoniasis. this is a study describing all the aspects of vaginal discharge associated with vaginitis , types , infections , treatment , prevention etc
please comment
thank u
India is the highest TB burden country accounting for more than one-fourth of the global incidence .Genital TB is found in 5-10% of women with infertility problems, with low rates in Australia (1%) and high rates of up to 19% in India (ICMR,2011)
Presentation on the description of normal and abnormal uterine bleeding, menstrual cycle, FIGO classification with PALM-COEIN, common differentials of AUB, assessment, diagnosis, and management.
Bacterial Vaginosis
Dr. Yashika
Causative agent : Gardnerella vaginalis
Clinical features:
Malodorous vaginal discharge.
(Homogenous, greyish white, adherent to vaginal wall)
No vaginal inflammation.
During pregnancy
preterm membrane rupture,
preterm labour,
chorioamnionitis.
Complications:
Recurrent infection leads to PID.
Development of PID following abortion.
Vaginal cuff cellulitis following hysterectomy.
Pregnancy complications.
Diagnosis
Amsel’s criteria :
Homogenous vaginal discharge
Vaginal discharge > 4.5
Positive whiff’s test
Presence of clue cells > 20% of cells.
Whiffs test:
Appearance of fishy (amine) odour when a drop of discharge is mixed with 10% solution of KOH.
Clue cells:
Presence of stippled epithelial cells.
Treatment:
Metronidazole 200 mg TDS x 7 days.
Clindamycin cream.
Metronidazole gel.
Yeast infections are generally caused by an organism called Candida albicans. Natural cures are simple, less expensive, and by far the most important point, they actually work. Get few tips for avoiding this disease with ease.
http://www.yeastinfectionheal.com/
Yeast infections are generally caused by an organism called Candida albicans. Natural cures are simple, less expensive, and by far the most important point, they actually work. Get few tips for avoiding this disease with ease.
http://www.yeastinfectionheal.com/
This presentation touches briefly on the vaginal discharges, both physiological and pathological, approach to management, and a brief touch on pelvic inflammatory disease.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
2. ETIOLOGY
Bacterial vaginosis
• Bacterial vaginosis is characterized by a complex change in the
vaginal flora, which leads to a reduction of the normally
dominant hydrogen-peroxide-producing lactobacilli
• These lactobacilli are replaced by an increased concentration of
other organisms, especially anaerobes
• These organisms, which break down vaginal peptides into
amines and cause the typical discharge in patients with bacterial
vaginosis, produce large amounts of proteolytic carboxylase
enzymes
3. ETIOLOGY
Bacterial vaginosis
• Up to 30% of patients treated for bacterial vaginosis have a
recurrence within 3 months. Routine treatment of women with
asymptomatic bacterial vaginosis is not recommended, mainly
due to low response rates to treatment and increased incidence
of candidiasis after therapy
• However, treatment of asymptomatic women with bacterial
vaginosis does result in a lower rate of subsequent Chlamydia
infection
• Treatment of male partners of patients with bacterial vaginosis
4. ETIOLOGY
Bacterial vaginosis
• Bacterial vaginosis diagnosed early in pregnancy is a strong risk
factor for preterm labor, preterm premature rupture of
membranes, low birth rate, and spontaneous abortion. However,
treatment of patients with asymptomatic infection with
metronidazole does not prevent preterm birth
5. ETIOLOGY
Trichomoniasis
• It represents the most prevalent sexually transmitted infection
worldwide
• Trichomonas vaginalis is a flagellated protozoan usually found in
the vagina, urethra, and paraurethral glands of infected patients
• It is associated with a high prevalence of co-infection with other
STIs
• Most male partners of female patients with a diagnosis of
trichomoniasis are also infected; hence, it is recommended to
6. ETIOLOGY
Vulvovaginal candidiasis (VVC)
• Candida species are present in about 20% to 50% of vaginal flora
of healthy asymptomatic women; It is not considered an STI
• Candida albicans is the most common cause of VVC
7. ETIOLOGY
Vulvovaginal candidiasis (VVC)
• Vulvovaginal candidiasis is not related to number of recent
sexual partners but may b related to increased frequency of
intercourse
• Risk factors for VVC include poorly-controlled diabetes mellitus,
broad-spectrum antibiotics that inhibit growth of normal vaginal
flora, high estrogen levels (e.g., when using oral contraceptive
pills, when having estrogen therapy, or during pregnancy),
immunosuppression (including patients with HIV, in whom it is
associated with a higher incidence and persistence of disease),
8. ETIOLOGY
Vulvovaginal candidiasis (VVC)
Uncomplicated VVC is defined as an infection with the following
characteristics:
• Sporadic or infrequent VVC
• Mild to moderate symptoms
• Likely to be C albicans species
• Presence in an immunocompetent patient.
Recurrent VVC is:
• Defined as infection that occurs 4 or more times per year
• Seen in about 5% to 8% of patients.
Complicated VVC:
• Includes patients with recurrent or severe VVC, non-albicans candidiasis, or
uncontrolled diabetes, or those who are immunocompromised or pregnant
• Is characterised by an increased incidence of candidal species other than C albicans in
patients with HIV and patients with recurrent candidiasis.
9. ETIOLOGY
Less common infectious causes
• Other, less common infectious causes of vaginitis include
chlamydial infection, gonorrheal infection, herpes simplex virus,
streptococcal infection, genital schistosomiasis (reported in
Africa)
• The role of Mycoplasma as a cause of vaginal discharge is still
being defined
11. Cervicitis due to herpes simplex virus; erosive inflammation
with accompanying paracervical purulency is seen
12. ETIOLOGY
Non-infectious causes
Include allergy or contact dermatitis (e.g., latex, sperm, douching,
dyes), chemical irritants (e.g., soaps, tampons, pads, condoms),
inadequate hygiene, atrophic vaginitis (estrogen deficiency),
foreign body (e.g., tampons, pessary, contraceptive devices) post-
puerperal atrophic vaginitis
13. ETIOLOGY
Pediatric
• Compared with the vagina of a woman of reproductive age, the
vagina of a prepubertal patient has a neutral pH without
antibodies to protect it from infection, is shorter and closer to
the rectum, and is exposed to much lower estrogen levels
• For these reasons, this age group is at increased risk for
vulvovaginitis, accounting for about 70% of all gynecological
complaints
14. ETIOLOGY
Pediatric
• Vaginal discharge in this age group is usually not caused by
infection and almost never caused by a malignancy
• Common causes of vaginal discharge in girls younger than 6
years include foreign body (45%), sexual abuse (18%), and
unknown diagnosis (36%)
15. RED FLAGS
• Trichomoniasis
• Chlamydia trachomatis infection
• Neisseria gonorrhoeae infection
• Cervical cancer
• Carcinoma of the fallopian tube
• Foreign body in children
• Sexual abuse
• Transmitted maternal birth canal infection
• Lymphoma of genital tract
16. CLINICAL HISTORY AND EXAMINATION
The initial history should include:
• Any new sexual partners
• Use of new soaps or detergents
• Douching
• Contraceptive vaginal ring or intrauterine device use
• Symptoms such as pelvic pain, itching, quality/quantity/odor of discharge
• Bacterial vaginosis typically presents with a thin discharge and
fishy odor ('whiff test'). Trichomoniasis presents with a purulent
malodorous discharge. Vulvovaginal candidiasis presents with a
white, cottage cheese discharge and pruritus
17. CLINICAL HISTORY AND EXAMINATION
• Vaginal culture for vulvovaginal candidiasis: should be obtained
to confirm diagnosis in patients with typical clinical features but
normal pH and negative wet mount microscopy. Should also be
obtained for patients with recurrent symptoms.
• Vaginal culture for trichomoniasis: should be considered if pH is
>4.5, if there are high polymorphonuclear leukocytes but no
motile trichomonads on wet mount microscopy, or if microscopy
is not available
18. CLINICAL HISTORY AND EXAMINATION
Women at risk for sexually transmitted infections
• In women at risk for sexually transmitted infections (those with
new, multiple partners, or partners with multiple partners, as
well as women younger than 25 years old) and profuse yellowish
vaginal discharge, a pelvic examination should be performed and
cultures and assays for Neisseria gonorrhoeae or Chlamydia
trachomatis obtained in addition to routine tests
• If the discharge is accompanied by pelvic pain and/or cervical
motion tenderness, the patient should be treated for pelvic
inflammatory disease (PID) according to local guidelines
19. CLINICAL HISTORY AND EXAMINATION
Recurrent vaginal discharge
Patients with recurrent vulvovaginal candidiasis should have the
following excluded: diabetes mellitus and immunocompromised
states, as well as for other type of Candida (e.g., Candida glabrata
), because they can be resistant to antifungal agents used in the
management of Candida albicans
20. CLINICAL HISTORY AND EXAMINATION
Atrophic vaginitis
• If the woman is postmenopausal and epithelium appears pale,
smooth, and shiny, then clinical diagnosis of atrophic vaginitis
may be considered
• Other tests may include estrogen levels, which are typically low;
microscopy negative for infection; and ultrasound of vaginal
lining
21. CLINICAL HISTORY AND EXAMINATION
Physiological post puerperal atrophic vaginitis
History of recent child birth with characteristic discharge (lochia
rubra, serosa, or alba) is diagnostic
Herpes simplex virus
Multiple crops of painful, shallow ulcers may indicate herpes
simplex virus cervicitis, which can be confirmed with viral cultures
and assays
22. CLINICAL HISTORY AND EXAMINATION
Behcet's syndrome
Will present with other features of the syndrome (e.g., aphthous
ulcers, skin lesions, and uveitis) in addition to vaginal ulceration
and discharge. Typically diagnosed clinically
Lichen planus
May be difficult to distinguish from atrophic vaginitis if there are
no extravaginal symptoms. Presents with shiny papules, which are
typically intensely itchy. Biopsy of vaginal wall confirms diagnosis.
23. BACTERIAL VAGINOSIS
History
• 50% to 75% asymptomatic
• Fishy odor especially after
intercourse
• Off-white, thin, homogeneous
discharge
• Rarely dysuria and dyspareunia
• Risk factors including new
sexual partner or >3 in past
year, douching, cigarette
smoking
Exam
• Discharge typically
homogeneous, thin, grayish-
white and odorous
26. TRICHOMONIASIS
History
• Purulent, malodorous, thin
discharge
• Can also present with
burning, pruritus, dysuria,
frequency, and dyspareunia
• Symptoms may be worse
during menstruation
Exam
• Typically, erythema of the
vulva and vaginal mucosa
• Vaginal discharge (green-to-
yellow, frothy) and strawberry
cervix may be present
31. VULVOVAGINAL CANDIDIASIS
History
• Vulvar pruritus, pain,
burning, swelling, redness,
soreness, irritation,
dyspareunia
• Usually little discharge but if
present, appears white and
clumpy, curd-like; more
frequent in patients with
diabetes
Exam
• Erythema of the vulva, vaginal
mucosa, and vulva edema
• Candida albicans discharge
usually thick, cottage,
cheese-like, adherent to
vagina wall; but may be thin
and loose with Candida
glabrata usually little
discharge
35. CHLAMYDIA TRACHOMATIS INFECTION
History
• Often asymptomatic; or
purulent or mucopurulent
discharge from endocervix
• Intermenstrual or postcoital
bleeding, dysuria, urinary
frequency, dyspareunia,
vulvovaginal irritation;
• Pain and fever rare
Exam
• Signs of cervicitis: cervix
friable, erythematous and
edematous, with purulent or
mucopurulent discharge
exude from cervix
• Possible cervical motion
Tenderness
• Yellow opaque endocervical
discharge, easily induced
cervical bleeding
36. NEISSERIA GONORRHOEAE INFECTION
History
• Asymptomatic; or vaginal
pruritus and/or a
mucopurulent discharge
• Abdominal pain or
dyspareunia suggests
extension to upper tract; may
lead to pelvic inflammatory
disease, ectopic pregnancy,
infertility if untreated
Exam
• Cervix normal or with friable
mucosa and purulent
discharge
37. STD CERVICITIS
An inflamed cervix (cervicitis) that appears red (beefy) and swollen
with pus coming out of the cervix is commonly seen in chlamydia
or gonococcal infections
38. PHYSIOLOGICAL LEUCORRHOEA IN ADULTS
History
• Usually consists of 1 to 4 mL
discharge per 24 hours; typically
transparent (high estrogen) or
thick mucousy (concentrated,
low estrogen), and white-to-
yellowish
• Typically odorless, but can also
be slightly malodorous
• More noticeable with higher
estrogen states (e.g. at
ovulation, pregnancy, use of
estrogen-progestogen
contraceptives)
Exam
• Scant to moderate, clear to
white discharge; otherwise
normal
• Normal discharge will not be
associated with symptoms or
foul smell or any inflammation
of the cervix or vagina
• The amount and the consistency
of normal vaginal discharge
change with the phase of the
menstrual cycle, age, pregnancy
status, and use of oral
contraceptive pills
40. PHYSIOLOGICAL LEUCORRHOEA IN ADULTS
The visible part of the cervix protrudes into the vaginal canal and
is covered by smooth, pink, squamous epithelium
41. PHYSIOLOGICAL LEUCORRHOEA IN
CHILDREN
History
• A few months before
menarche (9-13 years old)
• Grey-white physiological
discharge due to increase in
estrogen levels
Exam
• scant transparent, mucousy,
and white-to-yellowish
discharge
42. HERPES SIMPLEX VIRUS (HSV) INFECTION
History
• Superficial sores or ulcers
over the vulva
• Sometimes watery vaginal
discharge
• Appears 7-11 days after
primary infection
• General malaise and fever
possible
• Central nervous system
involvement rare
Exam
• Multiple crops of painful,
shallow ulcers over the vulva,
vagina and cervix
• Which often coalesce then
heal spontaneously without
scarring
46. ATROPHIC VAGINITIS
History
• Postmenopausal
• Itching, burning, discomfort,
dyspareunia
• Yellowish malodorous vaginal
discharge, or vaginal
bleeding
Exam
• Atrophic epithelium appears
pale, smooth, and shiny
• Inflammation with patchy
erythema, petechiae and
increased friability may be
present
47. POST PUERPERAL ATROPHIC VAGINITIS;
LOCHIA
History
• Recent childbirth, lochia rubra
(red) initially, then lochia serosa
(paler color) in the next few
days, lochia alba (white or
yellowish-white) from about the
10th day
• Itching, burning, discomfort,
dyspareunia
Exam
• Reddish discharge in first few
days, pinkish in next few days,
and whitish from approximately
10th postpartum day onward
• Findings of atrophic vaginitis
subsequently: epithelium
appears pale, smooth, and
shiny, and inflammation with
patchy erythema and increased
friability may be present
48. CERVICAL CANCER
History
• 4% present with vaginal
discharge
• Some can present with
malodorous vaginal discharge
indicating infection of a large,
necrotic tumour
• In late stage cervical cancer,
may have watery or foul-
smelling vaginal discharge
most likely from necrotic
Exam
• On speculum examination
possible watery, foul-
smelling discharge as well as
pelvic fungating mass
49. CERVICAL CANCER
The cervix is covered with a white discharge commonly seen in
vaginal candidiasis
There are multiple white raised lesions near the external os
50. CERVICAL CANCER
The discharge is cleaned and the lesions are better visible
They have a milky white color and raised margins; The SCJ is not visible
(After normal saline)
51. CERVICAL CANCER
An acetowhite area has developed on the TZ touching the SCJ
The acetowhitening is thin with irregular margins (After acetic
acid)
52. BEHCET'S SYNDROME
History
• Known hx of Behcet’s
syndrome; Recurrent
aphthous ulcers, genital
ulcerations occasionally
associated with vaginal
discharge, and uveitis leading
to blindness
Exam
• Recurrent genital ulcers in
vulva and vagina, which are
painful, and scarring
• Occasional vaginal discharge
53. EROSIVE LICHEN PLANUS
History
• Chronic eruption mostly on
flexor surfaces, mucous
membranes, and vulvar skin
• Lesions usually extremely
pruritic and sometimes
painful
Exam
• Violaceous, shiny papules
appearing mostly on flexor
surfaces, mucous
membranes, and vulvar skin
• Most lesions are located on
the inner aspects of the vulva,
especially on the labia minora
and vestibule